Cargando…

In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel

Racemic praziquantel (PZQ) is the drug of choice for the treatment of schistosomiasis. R‐Praziquantel (R‐PZQ) has been shown as the therapeutic form, whereas S‐PZQ is less efficacious and responsible for the bitter taste of the tablet. This study aimed at investigating the metabolism of R‐ and S‐PZQ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapungu, Nyasha Nicole, Li, Xueqing, Nhachi, Charles, Masimirembwa, Collen, Thelingwani, Roslyn Stella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376644/ https://www.ncbi.nlm.nih.gov/pubmed/32700798 http://dx.doi.org/10.1002/prp2.618

Ejemplares similares

Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir
por: Mutiti, Chenai Sheilla, et al.
Publicado: (2021)

Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry
por: Kanji, Comfort Ropafadzo, et al.
Publicado: (2023)

Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D6*17 Variant on the Formation of the Active Metabolite, Endoxifen
por: Kanji, Comfort Ropafadzo, et al.
Publicado: (2023)

Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers
por: Li, Xue-Qing, et al.
Publicado: (2021)

CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
por: Dhoro, Milcah, et al.
Publicado: (2015)

In Vitro Release and In Vivo Pharmacokinetics of Praziquantel Loaded in Different Polymer Particles
por: Pereira, Emiliane Daher, et al.
Publicado: (2023)

In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
por: Yang, Ruyi, et al.
Publicado: (2019)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics
por: Soko, Nyarai D., et al.
Publicado: (2018)

Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey
por: Simms, Victoria, et al.
Publicado: (2017)

African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development
por: Rajman, Iris, et al.
Publicado: (2017)

Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes
por: Muyambo, Sarudzai, et al.
Publicado: (2022)

In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections
por: Lamberton, Poppy H. L., et al.
Publicado: (2010)

Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models
por: Nono, Justin Komguep, et al.
Publicado: (2020)

Preparation and In Vitro/In Vivo Evaluation of Orally Disintegrating/Modified-Release Praziquantel Tablets
por: Wen, Xuemei, et al.
Publicado: (2021)

Study on In Vitro Metabolism and In Vivo Pharmacokinetics of Beauvericin
por: Yuan, Yu, et al.
Publicado: (2022)

Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models
por: Zdesenko, Grace, et al.
Publicado: (2020)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale
por: Bonate, Peter L., et al.
Publicado: (2018)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Healthcare Professionals’ Knowledge of Pharmacogenetics and Attitudes Towards Antimicrobial Utilization in Zambia: Implications for a Precision Medicine Approach to Reducing Antimicrobial Resistance
por: Mufwambi, Webrod, et al.
Publicado: (2021)

Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo
por: Yang, Zi-Yin, et al.
Publicado: (2021)

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)

Resolution of Praziquantel
por: Woelfle, Michael, et al.
Publicado: (2011)

In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
por: Wang, Xiaoli, et al.
Publicado: (2019)

CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
por: Langmia, Immaculate M., et al.
Publicado: (2021)

Simulation of metabolism-based herb-drug interaction: towards safe and efficacious use of NIPRD-AM1
por: Adzu, Bulus, et al.
Publicado: (2013)

Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel
por: Jacquot, Virginie, et al.
Publicado: (2021)

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe
por: Kuguyo, Oppah, et al.
Publicado: (2022)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo
por: Metwally, Dina M., et al.
Publicado: (2018)

Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects
por: Matimba, Alice, et al.
Publicado: (2009)

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
por: Wempe, Michael F, et al.
Publicado: (2012)

Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe
por: Ngara, Bernard, et al.
Publicado: (2021)

Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
por: Meyer, Thorsten, et al.
Publicado: (2009)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

The cytotoxicity study of praziquantel enantiomers
por: Sun, Qian, et al.
Publicado: (2016)

Promotion of Rat Hepatocarcinogenesis by Praziquantel
por: Shirai, Tomoyuki, et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_av1tqp2aq6ug40g0qpvarliu9r